Canimguide Therapeutics AB
Records under this name other than patents Canimguide Therapeutics AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Canimguide Therapeutics AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,796,777 | Methods of treating malignant tumors Lapsed on the fee record Ended Oct 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2025 | From the USPTO record |
| US 9,688,746 | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases Lapsed on the fee record Ended Jun 27, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 27, 2025 | From the USPTO record |
| US 9,657,059 | Immune system modulators Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |
| US 10,881,709 | Immune system modulators and compositions Lapsed on the fee record Ended Jan 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2025 | From the USPTO record |
| US 8,133,688 | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases Lapsed on the fee record Ended Mar 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 13, 2024 | From the USPTO record |
| US 8,110,347 | Diagnostic method for detecting cancer by measuring amount of cytokine like IL-6 Lapsed on the fee record Ended Feb 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 7, 2024 | From the USPTO record |
| US 9,120,874 | Methods of immunoregulation by albumin neo-structures Lapsed on the fee record Ended Sep 1, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 1, 2023 | From the USPTO record |
| US 7,960,126 | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases Lapsed on the fee record Ended Jun 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2023 | From the USPTO record |
| US 10,301,356 | Immune system modulators Lapsed on the fee record Ended May 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 28, 2023 | From the USPTO record |
| US 8,182,983 | Method for determining immune system affecting compounds Term ended Term ended May 27, 2023 · From the USPTO record | Term ended | Term ended May 27, 2023 | From the USPTO record |